Background: Chromogranin A (CgA) is used as a generic tumor marker for neuroendocrine tumors. Proton Pump Inhibitors (PPIs) are known to increase CgA, but it is not clear to what extent, and there is little information on how long PPIs need to be discontinued before the effect of PPIs has disappeared. Further, is it not known if this PPI effect is dependent on the CgA assay used. The objective of the study was to To determine the effect of 7 day treatment with a PPI and its discontinuation on CgA in serum and plasma comparing 4 CgA assays.
